Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis

• Published in: Nutrition journal Vol. 19; no. 1; p. 130
• Main Authors: Guo, Wenfang, Yi, Letai, Zhou, Baochang, Li, Minhui
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.12.2020; BioMed Central; BMC
• Subjects: Bias; biomedical research; Blood Glucose; Body weight; Chitin; Chitosan; Clinical trials; Complications and side effects; Diabetes; Diabetes mellitus; Dietary fiber; Fasting; Glucose; Glycated Hemoglobin - analysis; glycemic effect; glycohemoglobin; glycosylation; HbA1c; Health aspects; Hemoglobin; Human subjects; Humans; Hyperglycemia; Hypertension; Insulin; Insulin resistance; Intervention; Laboratory testing; Lipids; Meta-analysis; Metabolic Syndrome; Metabolic syndrome X; monitoring; nutrition; Overweight; patients; people; Properties; Public health; Review; Risk factors; Software; Supplements; Trial sequential analysis; China; Iran; United States > US; Trial sequential analysis; Chitosan; Glucose; HbA1c; Insulin; Meta-analysis

Chitosan supplementation has been shown to modulate glycemic levels; however, studies have reported conflicting results. The present meta-analysis with trial sequential analysis was conducted to verify the overall influence of chitosan on glycemic levels in patients with metabolic syndrome. The PubM...